Connecting COVID-19 to Cancer Research

Video

Dr. Adam Brufsky, an oncologist, compares viral and cancer immunity. Dr. Patrick Soon-Shiong connects the relation to COVID-19 vaccine research.

Dr. Adam Brufsky, an oncologist, compares viral and cancer immunity.

Dr. Patrick Soon-Shiong, CEO and chairman of ImmunityBio, weighs in on relevant questions for the COVID-19 vaccine race.

Newsletter

Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.

Subscribe Now!
Recent Videos
Related Content
Monoclonal Antibody Shows 84% Relative Risk Reduction of Symptomatic COVID-19 vs Placebo

Monoclonal Antibody Shows 84% Relative Risk Reduction of Symptomatic COVID-19 vs Placebo

John Parkinson
June 29th 2025
Article
A Passion for Infectious Disease Education and Communication

A Passion for Infectious Disease Education and Communication

Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc; and Ryan P. McNamara, PhD;Timothy Gauthier, PharmD, BCPS, BCIDP
June 16th 2025
Podcast
Gates Foundation Pledges $1.6 Billion to Gavi, the Vaccine Alliance

Gates Foundation Pledges $1.6 Billion to Gavi, the Vaccine Alliance

John Parkinson
June 25th 2025
Article
From Pathogen to Infectious Disease Diagnosis: Identifying a Novel Variant of Klebsiella Pneumoniae

From Pathogen to Infectious Disease Diagnosis: Identifying a Novel Variant of Klebsiella Pneumoniae

Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc ;Jose Alexander, MD, ABMM, ABAIM, FCCM, CIC, ASCP, BCMAS
December 23rd 2024
Podcast
FDA Approves Gilead’s Twice-Yearly Injectable Lenacapavir (Yeztugo) for HIV Prevention

FDA Approves Gilead’s Twice-Yearly Injectable Lenacapavir (Yeztugo) for HIV Prevention

Sophia Abene;Jared Baeten, MD, PhD
June 18th 2025
Article
Estimate Suggests 30% of Americans Express Vaccine Skepticism

Estimate Suggests 30% of Americans Express Vaccine Skepticism

Sophia Abene
June 18th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.